Prognostic Nomogram and Therapeutic Option of Cancer-Specific Death in the Patients with Metachronous Second Primary Lung Cancer

<div>Decision curve analysis for cancer-specific death model among metachronous SPLC by using competing risk model. (a) 1-year probability of cancer-specific death; (b) 5-year probability of cancer-specific death.</div>

Journal of Oncology

fig3

Figure 3

Figure 3: Prognostic Nomogram and Therapeutic Option of Cancer-Specific Death in the Patients with Metachronous Second Primary Lung Cancer 